Cardiology

Top Story

New studies will investigate long-term anticoagulant use

July 23, 2016

The Patient-Centered Outcomes Research Institute Board of Governors announced the approval of $6.5 million to fund two studies that will compare the effectiveness of novel oral anticoagulants for prevention of venous thromboembolism and pulmonary embolism, according to a press release.

In addition to warfarin, four novel oral anticoagulants — apixaban (Eliquis, Bristol-Myers Squibb), dabigatran (Pradaxa, Boehringer Ingelheim), edoxaban (Savaysa, Daiichi Sankyo) and rivaroxaban (Xarelto, Janssen) — are now available for use in the United States to treat clots. These novel oral anticoagulants are frequently used for longer than the standard 3-month treatment period to prevent formation of additional clots, but the comparative safety and effectiveness of extended use is unclear, according to information in the release.

In the Journals

Female physicians make 'substantially' less than male counterparts

July 22, 2016
Significant salary differences exist between male and female physicians at public medical schools, according to findings published in JAMA Internal Medicine. This gap…
FDA News

Vascular closure device approved for US market by FDA

July 22, 2016
Vasorum Ltd. announced that its vascular closure device has been approved by the FDA for use in interventional cardiology and interventional radiology procedures. The…

Nearly half of physicians see fewer patients each day due to EHR use

July 22, 2016
Physicians have mixed feelings about electronic health record usage, according to a report published by Physicians Practice. The 2016 Tech Report included an annual…
FDA News

FDA denies AstraZeneca request to block approvals of generic rosuvastatin

July 22, 2016
The FDA has denied AstraZeneca’s citizen petition for a temporary restraining order to prevent approval of any abbreviated new drug applications for generic…
More News Headlines »
CME

The Patient with CAD Who Develops Peripheral Arterial Disease

No commercial support for this activity.

The prevention of cardiovascular disease (CVD) is crucial in light of its associated mortality, morbidity, and economic…
More »
Video
Meeting News Coverage

VIDEO: New lessons in ACS provide insight on treatment approaches, troponin assays

July 9, 2016
More »
Featured
Highlights from ACC Scientific Session 2016

Highlights from ACC Scientific Session 2016

Video
Meeting News Coverage

VIDEO: President-elect discusses goals for AAHFN in 2016-2017

June 26, 2016
More »
morganatic-roan
morganatic-roan